Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Dr Reddys Laboratories Ltd

Pharmaceuticals & Biotechnology | Large Cap

Dr Reddys Laboratories Ltd Health Insights
Health Score : 6.49Health Score : 6.49

Dr. Reddy's Laboratories demonstrates a mixed financial performance. The company shows strong solvency, driven by low debt levels. Growth prospects are also promising, fueled by robust revenue and earnings per share increases. Profitability is a highlight, supported by healthy gross profit and operating margins. However, liquidity appears weak, potentially posing short-term financial challenges. Efficiency is also a concern, with some turnover ratios indicating underutilization of assets. While interest coverage is strong, the absence of equity dividend coverage raises questions about shareholder returns. Overall, Dr. Reddy's exhibits solid long-term potential but needs to address its liquidity and efficiency issues to ensure sustainable growth and stability. The healthcare sector's inherent stability and growing demand for pharmaceuticals provide a favorable backdrop for the company, but effective financial management is crucial to capitalize on these opportunities.

Latest Report

View All
Quarterly Financial Results Q3 FY 2025–26

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Dr Reddys Laboratories Ltd Health Insights
Health Score : 6.49Health Score : 6.49

Dr. Reddy's Laboratories demonstrates a mixed financial performance. The company shows strong solvency, driven by low debt levels. Growth prospects are also promising, fueled by robust revenue and earnings per share increases. Profitability is a highlight, supported by healthy gross profit and operating margins. However, liquidity appears weak, potentially posing short-term financial challenges. Efficiency is also a concern, with some turnover ratios indicating underutilization of assets. While interest coverage is strong, the absence of equity dividend coverage raises questions about shareholder returns. Overall, Dr. Reddy's exhibits solid long-term potential but needs to address its liquidity and efficiency issues to ensure sustainable growth and stability. The healthcare sector's inherent stability and growing demand for pharmaceuticals provide a favorable backdrop for the company, but effective financial management is crucial to capitalize on these opportunities.

Latest Report

View All
Quarterly Financial Results Q3 FY 2025–26

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

32.97

Neutral

Industry Median

28.62

Neutral
Neutral

Large Cap Median

30.25

Neutral

P/E RATIO

25.31

P/B RATIO

2.80

Neutral

Industry Median

3.17

Neutral
Undervalued

Large Cap Median

5.04

Undervalued

P/S RATIO

3.29

Neutral

Industry Median

3.42

Neutral
Undervalued

Large Cap Median

5.48

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

13.94

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1272.1 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Quarterly Report21st Jan 26

Quarterly Financial Results Q3 FY 2025–26

NEUTRAL SENTIMENT

Concall Report24th Oct 25

Q2FY26 Earnings Call

NEUTRAL SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 8.00

The company exhibits strong growth, driven by robust increases in revenue, operating profit, and earnings per share. This indicates successful expansion and effective management strategies. However, the absence of net income growth is concerning and needs to be addressed to ensure sustainable growth. It also shows the company's ability to be on the top.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate13.1114.513.5416.543.23
Operating Profit Growth Rate-2.7471.7122.617.74-24.49
Earnings Per Share (EPS) Growth11.76106.423.511.35-25.82
Asset Growth Rate11.888.2820.423.8321.03
Net Income Growth Rate11.78106.5523.762.64-27.37
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 6.80

The financial ratios present a mixed picture. Book value and capex are good but Adjusted EPS is not good. Improving adjusted EPS would provide a more comfortable buffer for handling unforeseen expenses or dips in revenue. The financial performance of the company is good but it can be improved in the future.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
GoodCash Earnings Per Share (Cash EPS)Good
ExcellentBook Value Per ShareExcellent
GoodDividend Per Share (DPS)Good
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)25.4255.3966.4168.5349.05
Cash Earnings Per Share (Cash EPS)40.3369.3684.9289.5174.01
Book Value Per Share231.47280.55340.41404.2451.1
Dividend Per Share (DPS)6.038.128.028.138.04
Capital Expenditures (CapEx)15731879263633163669
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 7.20

The profitability ratios are generally strong, indicating the company's ability to generate profits from its operations. High gross profit and operating margins suggest efficient cost management and pricing strategies. However, the absence of return on equity and net margin is concerning and needs to be addressed to ensure sustainable profitability. It also shows the company's ability to be on the top.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
PoorReturn on Equity (ROE)Poor
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
PoorNet MarginPoor
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin12.0821.1623.0720.9613.04
Return on Capital Employed (ROCE)1427272314
Return on Equity (ROE)11.3619.3519.7417.0610.97
Return on Assets (ROA)12.6720.0920.4617.811.1
Operating Margin17.4926.2328.3226.1819.15
Net Margin10.1318.2719.9117.5412.34
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The efficiency ratios present a mixed picture. While days sales in inventory and receivable days are efficient, the turnover ratios are low. This indicates the company is not effectively utilizing its assets to generate revenue. Improving asset turnover could enhance overall operational efficiency. It also shows the company's scope for improvement.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.652.682.691.791.53
Inventory Turnover Ratio3.933.913.843.833.97
Receivables Turnover Ratio3.73.543.673.823.52
Days Sales in Inventory Ratio92.8893.3595.0595.391.94
Receivable Days98.65103.1199.4695.55103.69
Capital Turnover Ratio1.081.050.970.950.86
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The coverage ratios show a mixed performance. While the interest coverage ratio is strong, indicating a good ability to meet interest obligations, the absence of equity dividend coverage is a significant concern. This suggests that the company is not providing dividends to its shareholders, which may deter investors. This also shows the company's need to improve on dividend policies.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio32.8943.2943.1128.1415.42
Equity Dividend Coverage Ratio4.356.678.338.336.25
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits strong solvency, indicating a solid financial structure and a low risk of financial distress. Low debt ratios suggest a conservative approach to financing, which reduces financial risk. High equity ratios further reinforce financial stability, providing a strong foundation for future growth and investment. This also shows the company's long term stability.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.030.010.030.030.04
Debt to Equity Ratio0.030.010.030.030.04
Equity Ratio0.970.990.970.970.96
Debt To Asset Ratio0.020.010.020.020.02
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position is weak, suggesting potential difficulties in meeting its short-term obligations. A low cash ratio indicates limited immediate liquidity, which could be a concern for day-to-day operations. While low liquidity can be a concern but it also can lead to efficient management of resources. Improving current and quick ratios would provide a more comfortable buffer for handling unforeseen expenses or dips in revenue.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.81.952.251.711.56
Quick Ratio1.281.391.61.191.15
Cash Ratio0.250.20.180.180.18
Operating Cash Flow Ratio0.290.680.460.340.3
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 10 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Abbott India Ltd8.6835.89Neutral1892.00730.391552.00
2Glaxosmithkline Pharmaceuticals Ltd8.3838.14Neutral1309.0059.731036.00
3Alkem Laboratories Ltd8.0827.91Neutral3005.00182.762351.00
4Lupin Ltd7.8420.16Neutral8816.00139.255355.00
5Cipla Ltd7.6228.15Neutral5883.0043.523862.00
6Mankind Pharma Ltd7.6152.10Highly Overvalued3617.0049.341938.00
7Zydus Lifesciences Ltd7.6021.38Neutral8475.0035.385124.00
8Laurus Labs Ltd7.1085.84Neutral1778.0013.72890.00
9Dr Reddys Laboratories Ltd6.4925.31Neutral6454.0038.584158.00
10Glenmark Pharmaceuticals Ltd6.3645.87Neutral4572.00-7.121362.00
Management Assessment Summary
GreenStrong Management

Dr. Reddy's Laboratories showcases proficient management, underscored by consistent financial expansion and effective deployment of capital. The company's steady revenue and profit escalation, bolstered by sound operating profit margins, highlight its operational efficacy. Prudent management of liabilities and a dependable dividend distribution strategy emphasize the management's dedication to fiscal prudence and enriching shareholder value. The confidence of diverse investors, including substantial foreign and domestic institutional participation, further validates the company's strategic path.

Category Metric Value Assessment
PROS Sales Growth (TTM) 19.89% Strong revenue expansion
Profit Growth (3Y) 39% Robust profit growth
ROCE (Current) 23% Efficient use of capital
CONS Promoter Holding 26.64% Relatively Low Promoter Holding
ExcellentFinancial Performance & GrowthExcellent
ExcellentCapital Efficiency & ReturnsExcellent
GoodFinancial Health & PrudenceGood
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Dr. Reddy's Laboratories encounters moderate risk. The volatility in the company's segment performance, influenced by market conditions and regulatory changes, presents a risk. The company's global operations expose it to foreign exchange and interest rate risks, which could impact profitability.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
AverageRegulatory compliance cost trendsAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

03.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101267.29Bullish
  3. SMA 201266.87Bullish
  4. SMA 501272.76Bullish
  5. EMA 101268.27Bullish
  6. EMA 201268.58Bullish
  7. EMA 501271.87Bullish
  8. DEMA 101269.20Bullish
  9. DEMA 201266.75Bullish
  10. DEMA 501266.15Bullish
  11. TEMA 101271.15Bullish
  12. TEMA 201267.60Bullish
  13. TEMA 501266.96Bullish
  14. MACD-1.06Bullish
  15. ADX20.78Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI55.24Neutral
  3. CCI157.37Overbought
  4. ROC 90.62Bullish
  5. ROC 140.28Bullish
  6. ROC 25-0.28Bearish
  7. Stoch K51.32Neutral
  8. Stoch D38.32Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1273.01Neutral
  3. BB Middle1266.87Neutral
  4. BB Lower1260.73Neutral
  5. ATR6.28Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI82.47Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101267.88Bullish
  3. SMA 201271.81Bullish
  4. SMA 501273.44Bearish
  5. EMA 101269.36Bullish
  6. EMA 201270.70Bullish
  7. EMA 501276.48Bearish
  8. DEMA 101268.76Bullish
  9. DEMA 201267.69Bullish
  10. DEMA 501266.84Bullish
  11. TEMA 101270.14Bullish
  12. TEMA 201268.18Bullish
  13. TEMA 501264.39Bullish
  14. MACD-2.16Bullish
  15. ADX18.40Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI51.03Neutral
  3. CCI0.66Neutral
  4. ROC 90.36Bullish
  5. ROC 140.11Bullish
  6. ROC 25-0.39Bearish
  7. Stoch K46.38Neutral
  8. Stoch D32.55Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1284.25Neutral
  3. BB Middle1271.81Neutral
  4. BB Lower1259.38Neutral
  5. ATR8.84Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI72.02Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101271.61Bullish
  3. SMA 201273.46Bearish
  4. SMA 501294.22Bearish
  5. EMA 101270.90Bullish
  6. EMA 201274.44Bearish
  7. EMA 501283.06Bearish
  8. DEMA 101268.44Bullish
  9. DEMA 201266.70Bullish
  10. DEMA 501277.67Bearish
  11. TEMA 101269.15Bullish
  12. TEMA 201267.20Bullish
  13. TEMA 50N/AN/A
  14. MACD-5.38Bullish
  15. ADX14.06Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI47.53Neutral
  3. CCI-52.34Neutral
  4. ROC 9-0.55Bearish
  5. ROC 140.08Bullish
  6. ROC 250.80Bullish
  7. Stoch K26.25Neutral
  8. Stoch D21.03Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1284.78Neutral
  3. BB Middle1273.46Neutral
  4. BB Lower1262.15Neutral
  5. ATR14.98Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI45.89Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 101273.22Bearish
  3. SMA 201284.73Bearish
  4. SMA 501282.68Bearish
  5. SMA 1001274.22Bearish
  6. SMA 2001264.00Bullish
  7. EMA 101274.77Bearish
  8. EMA 201280.82Bearish
  9. EMA 501282.36Bearish
  10. EMA 1001275.67Bearish
  11. EMA 2001266.76Bullish
  12. DEMA 101268.49Bullish
  13. DEMA 201273.02Bearish
  14. DEMA 501287.97Bearish
  15. DEMA 1001287.75Bearish
  16. DEMA 2001280.66Bearish
  17. TEMA 101269.45Bullish
  18. TEMA 201265.34Bullish
  19. TEMA 501283.52Bearish
  20. TEMA 1001291.92Bearish
  21. TEMA 2001282.72Bearish
  22. MACD-6.39Bearish
  23. ADX14.74Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI45.29Neutral
  3. CCI-63.10Neutral
  4. ROC 14-1.42Bearish
  5. ROC 25-2.42Bearish
  6. Stoch K34.03Neutral
  7. Stoch D29.98Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1325.94Neutral
  3. BB Middle1284.73Neutral
  4. BB Lower1243.52Neutral
  5. ATR24.59Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI50.05Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 201277.58Bearish
  3. SMA 501264.43Bullish
  4. EMA 201280.39Bearish
  5. EMA 501265.77Bullish
  6. DEMA 201294.71Bearish
  7. DEMA 501284.41Bearish
  8. TEMA 201299.78Bearish
  9. TEMA 501282.49Bearish
  10. MACD10.82Bullish
  11. ADX11.35Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI50.60Neutral
  3. CCI35.08Neutral
  4. ROC 14-2.18Bearish
  5. ROC 25-0.22Bearish
  6. Stoch K56.72Neutral
  7. Stoch D63.23Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1353.77Neutral
  3. BB Middle1277.58Neutral
  4. BB Lower1201.38Neutral
  5. ATR64.99Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI55.74Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 61276.18Bullish
  3. SMA 121262.58Bullish
  4. SMA 241263.18Bullish
  5. EMA 61281.80Bullish
  6. EMA 121265.45Bullish
  7. EMA 241235.50Bullish
  8. DEMA 61301.70Bullish
  9. DEMA 121288.58Bullish
  10. DEMA 241305.84Bearish
  11. TEMA 61309.90Bearish
  12. TEMA 121290.85Bullish
  13. TEMA 241283.51Bullish
  14. MACD108.76Bearish
  15. ADX9.93Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI56.29Neutral
  3. CCI75.33Neutral
  4. ROC 255.05Bullish
  5. ROC 5051.73Bullish
  6. Stoch K58.90Neutral
  7. Stoch D61.74Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1366.77Neutral
  3. BB Middle1246.45Neutral
  4. BB Lower1126.14Neutral
  5. ATR126.08Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI63.65Neutral